Skip to content

A Study to know the effect of siddha medicine Mahavallathy legiyam in the treatment of valiazhal keelvayu (Rheumatoid arthritis)

CLINICAL EVALUATION OF MAHAVALLATHY LEGIYAM (INTERNAL MEDICINE) AND KUNTHIRIKA THAILAM (EXTERNAL MEDICINE) IN THE MANAGEMENT OF UTHIRA VATHA SURONITHAM (RHEUMATOID ARTHRITIS) - yes

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089651
Enrollment
30
Registered
2025-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M200- Deformity of finger(s)

Interventions

Intervention1: Mahavallathy legiyam: A Compound herbal drug indicated to treat vali azhal keelvayu(rheumatoid arthritis) adviced to intake 5grams for 90 days Control Intervention1: Mahavallathy legiy

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: adult with rheumatoid arthritis based on eular and acr score lessthen six patient with moderate das score 3.2 to 5.1 patient who are willing to attend opd or willing for admisson in ipd patient who are willing to undergo radiological investigation and other laboratory investigation patient who are willing to sign the informed consent starting that he and she will consciously stick to the treatment during 90 days byt can stop opt out of the trial of his and her own conscious discretion

Exclusion criteria

Exclusion criteria: pregnancy and lactating mother uncontrolled diabetes mellitus hba1cmore then 8 and uncontrolledd hypertension recent treatment with steroid ,history of trauma known case of any other arthritis extra articular involvement of rheumatoid arthritis except anaemia

Design outcomes

Primary

MeasureTime frame
The primary outcome will be Reduction of pain and swelling of the joints, Improvement in the movement of affected joints, and Reduction of disability (DAS SCALE)Timepoint: The primary outcome will be Reduction of pain and swelling of the joints, Improvement in the movement of affected joints, and Reduction of disability (DAS SCALE)

Secondary

MeasureTime frame
Improvement in the quality of life. (Qualisex questionnaire)Timepoint: 90 days

Countries

India

Contacts

Public ContactDr H NALINI SOFIA

National Institute of Siddha

dr.h.nalinisofia@gmail.com8939899363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026